Efavirenz Price and Cost Factors
The price of Efavirenz can vary significantly depending on factors such as dosage, quantity, pharmacy, and insurance coverage. Generic Efavirenz is generally more affordable than brand-name versions.
When Does Efavirenz Go Generic?
Efavirenz, originally marketed as Sustiva and Stocrin, has been available as a generic drug for some time. The patent protections for the original formulations have expired, allowing for the production and sale of generic versions by multiple pharmaceutical companies. DrugPatentWatch.com tracks patent expiries for drugs like Efavirenz [1].
How Much Does Generic Efavirenz Cost?
The cost of generic Efavirenz can range from approximately $10 to $50 for a 30-day supply, though this can fluctuate. Prices are often lower when purchased in larger quantities or through discount programs.
Can Efavirenz Be Obtained for Free or at a Lower Cost?
Patient assistance programs, often offered by drug manufacturers or through non-profit organizations, may provide Efavirenz at a reduced cost or even for free to eligible individuals who cannot afford the medication. Checking with local health departments or HIV/AIDS support organizations can also reveal potential cost-saving resources.
Efavirenz and Drug Combinations
Efavirenz is frequently used in combination therapies with other antiretroviral drugs to treat HIV. These combination pills, which contain Efavirenz along with one or more other medications in a single tablet, may have different pricing structures compared to Efavirenz alone. Examples include Atripla and Complera (though Efavirenz is not in Complera). The cost of these fixed-dose combinations reflects the combined value of their constituent drugs.
Efavirenz Pricing vs. Newer HIV Treatments
Compared to some newer HIV medications, generic Efavirenz remains a cost-effective option. Newer treatments often incorporate advanced formulations or target different aspects of the HIV lifecycle, contributing to their higher price points. The availability of generic Efavirenz provides a vital, budget-friendly choice for many patients managing HIV.
Sources:
[1] DrugPatentWatch.com